Literature DB >> 21606014

Quantifying differences in breast cancer survival between England and Norway.

Paul C Lambert1, Lars Holmberg, Fredrik Sandin, Freddie Bray, Karen M Linklater, Arnie Purushotham, David Robinson, Henrik Møller.   

Abstract

BACKGROUND: Survival from breast cancer is lower in the UK than in some other European countries. We compared survival in England and Norway by age and time from diagnosis.
METHODS: We included 303,648 English and 24,919 Norwegian cases of breast cancer diagnosed 1996-2004 using flexible parametric relative survival models, enabling improved quantification of differences in survival. Crude probabilities were estimated to partition the probability of death due to all causes into that due to cancer and other causes and to estimate the number of "avoidable" deaths.
RESULTS: England had lower relative survival for all ages with the difference increasing with age. Much of the difference was due to higher excess mortality in England in the first few months after diagnosis. Older patients had a higher proportion of deaths due to other causes. At 5 years post diagnosis, a woman aged 85 in England had probabilities of 0.35 of dying of cancer and 0.32 of dying of other causes, whilst in Norway they were 0.26 and 0.35. By eight years the number of "avoidable" all-cause deaths in England was 1020 with the number of "avoidable" breast cancer related deaths 1488.
CONCLUSION: Lower breast cancer survival in England is mainly due to higher mortality in the first year after diagnosis. Crude probabilities aid our understanding of the impact of disease on individual patients and help assess different treatment options. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21606014     DOI: 10.1016/j.canep.2011.04.003

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  12 in total

1.  Avoidable deaths and random variation in patients' survival.

Authors:  K Seppä; T Hakulinen; E Läärä
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

2.  Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.

Authors:  Sharareh Taghipour; Dragan Banjevic; Joanne Fernandes; Anthony B Miller; Neil Montgomery; Andrew K S Jardine; Bart J Harvey
Journal:  BMC Cancer       Date:  2012-07-19       Impact factor: 4.430

3.  Comparison of different approaches to estimating age standardized net survival.

Authors:  Paul C Lambert; Paul W Dickman; Mark J Rutherford
Journal:  BMC Med Res Methodol       Date:  2015-08-15       Impact factor: 4.615

4.  The loss in expectation of life after colon cancer: a population-based study.

Authors:  Therese M-L Andersson; Paul W Dickman; Sandra Eloranta; Annika Sjövall; Mats Lambe; Paul C Lambert
Journal:  BMC Cancer       Date:  2015-05-17       Impact factor: 4.430

5.  Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma.

Authors:  M J Rutherford; L Ironmonger; N Ormiston-Smith; G A Abel; D C Greenberg; G Lyratzopoulos; P C Lambert
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.

Authors:  Elena Raffetti; Maria Concetta Postorino; Francesco Castelli; Salvatore Casari; Filippo Castelnuovo; Franco Maggiolo; Elisa Di Filippo; Alessandro D'Avino; Andrea Gori; Nicoletta Ladisa; Massimo Di Pietro; Laura Sighinolfi; Fabio Zacchi; Carlo Torti
Journal:  BMC Public Health       Date:  2016-08-25       Impact factor: 3.295

7.  stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.

Authors:  Sarwar Islam Mozumder; Mark J Rutherford; Paul C Lambert
Journal:  Stata J       Date:  2017       Impact factor: 2.637

8.  Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.

Authors:  S Walters; C Maringe; J Butler; B Rachet; P Barrett-Lee; J Bergh; J Boyages; P Christiansen; M Lee; F Wärnberg; C Allemani; G Engholm; T Fornander; M L Gjerstorff; T B Johannesen; G Lawrence; C E McGahan; R Middleton; J Steward; E Tracey; D Turner; M A Richards; M P Coleman
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

9.  Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions.

Authors:  Sally R Hinchliffe; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2013-02-06       Impact factor: 4.615

10.  Analysing population-based cancer survival - settling the controversies.

Authors:  Maja Pohar Perme; Jacques Estève; Bernard Rachet
Journal:  BMC Cancer       Date:  2016-12-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.